Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
The AD8, officially known as the Ascertain Dementia 8-item Questionnaire, is a brief screening tool designed to identify cognitive changes that may warrant further evaluation. Created by the Knight Alzheimer Disease Research Center at Washington University in St. Louis, the AD8 consists of eight straightforward yes-or-no questions that assess whether someone has experienced changes in memory, thinking, or daily functioning. If you’ve ever wondered whether a parent or spouse’s occasional forgetfulness is normal aging or something that needs medical attention, the AD8 is one of the most accessible tools available to help answer that question. The AD8 works by asking someone who knows the person well—a spouse, adult child, or close friend—to report whether they’ve noticed specific changes over the past several years.
For example, rather than asking “Do you forget things?” the AD8 asks “Has the person had difficulty remembering important events or appointments that they would normally remember?” This specificity matters. A score of two or more positive responses suggests that cognitive screening may be warranted, though the AD8 is important to understand as a starting point for conversation with a healthcare provider, not as a diagnosis in itself. What makes the AD8 valuable is its simplicity and practical application. A busy family caregiving while working full-time can complete it in minutes. A healthcare clinic can administer it during a routine visit. Yet despite its brevity, validation studies show the AD8 has sensitivity greater than 84% and specificity greater than 80% for detecting cognitive impairment—meaning it catches real cases most of the time while avoiding excessive false alarms.
Table of Contents
- What Do the AD8 Questions Actually Assess?
- How the Scoring Works and What It Means
- How the AD8 is Administered and Who Completes It
- Accuracy and Reliability: How Well Does the AD8 Actually Work?
- Key Limitations and What the AD8 Cannot Do
- Comparing AD8 to Other Cognitive Screening Tools
- What Happens After a Positive AD8 Screening?
- Conclusion
What Do the AD8 Questions Actually Assess?
The eight questions evaluate cognitive and functional changes across six key domains: memory, orientation to time and place, judgment and problem-solving ability, involvement in community affairs, participation in hobbies and interests, and personal care and grooming. None of the questions ask directly about diagnosis or disease. Instead, they ask about observable changes in everyday life that family members or close friends are positioned to notice. For instance, one question asks whether the person has difficulty handling finances or paying bills when they previously managed them without difficulty. Another asks whether they have trouble finding their way around familiar places. A third explores whether they have trouble making decisions or solving problems.
Together, these questions create a functional snapshot. If someone has started forgetting appointments, getting lost in familiar neighborhoods, struggling to manage household tasks, or becoming increasingly dependent on others for daily routines, the ad8 is likely to pick up on those patterns. The tool doesn’t require a medical degree to interpret; a family member who spends time with the person being screened can provide the answers. The beauty of this approach is that it captures real-world changes rather than abstract test performance. Someone might score well on a memory test in a doctor’s office because the testing environment is quiet and structured, while at home they repeatedly forget to turn off the stove or lose track of their medications. The AD8’s informant-based approach catches the latter pattern.
How the Scoring Works and What It Means
The AD8 uses a simple scoring system: each question is answered “yes” (indicating a change has occurred) or “no” (indicating no change). A score of 1 or fewer positive responses generally suggests no significant cognitive impairment. A score of 2 or more positive responses is considered a positive screen, meaning the person should have further evaluation by a healthcare provider. This cutoff—≥2—was determined through validation research to balance sensitivity and specificity. The critical limitation here is that a positive AD8 score does not mean someone has dementia or any specific diagnosis. The AD8 is a screening tool, not a diagnostic test. Think of it similarly to how high blood pressure during a routine visit doesn’t diagnose heart disease—it flags that further investigation is needed.
A positive AD8 means a conversation with a doctor should happen, potentially followed by more comprehensive cognitive testing such as the Mini-Cog, Montreal Cognitive Assessment (MoCA), or neuropsychological evaluation. Some older adults with positive AD8 scores have normal aging, while others have mild cognitive impairment, and still others have early dementia. Only a full clinical evaluation can distinguish between these possibilities. Another important point: the AD8 relies entirely on the informant’s perception and memory. If the person answering the questions hasn’t spent regular time with the person being screened, their answers may not accurately reflect cognitive changes. For example, an adult child who visits a parent twice a year may miss gradual memory changes that a spouse who lives with them would immediately recognize. Conversely, an overly anxious family member might overestimate normal aging as pathological change. This human element is both a strength and a potential source of error.
How the AD8 is Administered and Who Completes It
The AD8 was originally developed as an informant-based interview, meaning it was designed to be completed by someone who regularly interacts with the person being screened—typically a spouse, adult child, or close friend. This makes sense because memory problems or behavioral changes are often most obvious to people who see someone regularly. A person with early cognitive impairment may not fully recognize their own memory lapses, but a spouse or family member notices immediately when they start repeating stories or forgetting appointments. Over time, the AD8 has become flexible in its administration.
While the informant-based version remains the most validated, healthcare providers now administer it in multiple ways: as a paper form that family members complete at home and bring to an appointment, as questions read aloud during an office visit, via phone call with a family member, and even in self-administered form where the person being screened answers about their own perceived changes. Each method has tradeoffs. Self-administration is quickest and doesn’t require coordinating with a family member, but it may underestimate cognitive changes because people with early dementia often lack awareness of their own deficits. Informant-based administration is more reliable for detecting subtle changes, but it requires identifying someone who knows the person well enough to notice changes.
Accuracy and Reliability: How Well Does the AD8 Actually Work?
Research published in peer-reviewed journals demonstrates that the AD8 performs well as a screening tool. In validation studies, the AD8 showed sensitivity greater than 84%—meaning it correctly identified more than 84 out of 100 people with actual cognitive impairment. It also showed specificity greater than 80%—meaning it correctly identified more than 80 out of 100 people without cognitive impairment. In practical terms, if your mother scores 2 or higher on the AD8 and a family friend who sees her regularly agrees that changes have occurred, there is a reasonably strong likelihood that cognitive evaluation is warranted. However, these statistics come with important caveats.
Sensitivity of 84% means the tool misses about 16 out of 100 cases of cognitive impairment—no screening tool is perfect. Someone could have early cognitive changes and still score below the cutoff, particularly if the informant doesn’t notice subtle changes or if changes are very recent. Additionally, the accuracy figures in published studies come from specific research populations, often older adults in healthcare settings with confirmed diagnoses. In everyday clinical practice, results may vary. The AD8 is most reliable when used in the context it was designed for: family members or close friends answering about someone they see regularly, with results then shared with a healthcare provider who can conduct a more thorough evaluation.
Key Limitations and What the AD8 Cannot Do
The most important limitation of the AD8 is that it is a screening tool only—not a diagnostic tool. A positive score does not mean someone has dementia, mild cognitive impairment, or any other specific condition. It means further evaluation is necessary. This distinction matters tremendously. Families sometimes receive a positive AD8 result and assume a dementia diagnosis is imminent, leading to unnecessary anxiety. Others score positive and then delay seeking medical evaluation because they assume the test is unreliable. In reality, the AD8 is doing its job correctly—it is designed to cast a slightly wider net to ensure that people with cognitive changes don’t get overlooked.
Another limitation is that the AD8 does not differentiate between types of cognitive impairment or causes of cognitive changes. A positive AD8 could reflect Alzheimer’s disease, vascular dementia, Lewy body disease, normal pressure hydrocephalus, medication side effects, depression, thyroid problems, vitamin B12 deficiency, or a combination of factors. Determining the cause requires medical evaluation, imaging, blood work, and sometimes specialist consultation. The AD8 simply flags that something warrants investigation. Additionally, the AD8 may be less reliable in certain populations. It works best in English-speaking settings and has been translated to other languages, but cultural factors in how families discuss aging and cognitive changes can affect how questions are interpreted. The AD8 also may not be as sensitive in detecting very mild cognitive changes or in detecting cognitive changes in highly educated individuals who have greater cognitive reserve and may perform within normal ranges despite actual decline. Someone who was a surgeon or professor may notice significant cognitive changes in themselves that aren’t yet visible on a screening questionnaire.
Comparing AD8 to Other Cognitive Screening Tools
The AD8 is one of several screening tools available in clinical practice. The Mini-Cog takes about three minutes and combines a three-item recall task with a clock-drawing test. The Montreal Cognitive Assessment (MoCA) takes about 10 minutes and assesses multiple cognitive domains in more detail. The MMSE (Mini-Mental State Examination) is the gold standard for many clinicians but requires more time and healthcare provider administration. Each tool has different strengths.
Where the AD8 stands out is in its brevity and the fact that it requires no special materials, no medical expertise to administer, and no cognitive testing on the person being screened. This makes it ideal for primary care settings, screening events, and when family members want an objective assessment tool before scheduling a doctor’s appointment. Someone concerned about a parent’s memory can complete the AD8 in two minutes and have actionable information. In contrast, administering a full MoCA or neuropsychological battery requires a healthcare provider’s time and office resources. The tradeoff is that the AD8 is less detailed—it screens broadly rather than pinpointing specific cognitive domains.
What Happens After a Positive AD8 Screening?
A positive AD8 score should prompt a conversation with a healthcare provider—typically the person’s primary care doctor or a neurologist. That conversation should include discussion of the specific changes the family member has noticed, when those changes started, and whether they’ve been gradual or sudden. It should also include a medical history: recent medications, thyroid function, vitamin B12 levels, mood changes, sleep quality, and other factors that can affect cognition.
From there, the doctor may order blood work to rule out reversible causes of cognitive change, perform a more detailed cognitive assessment, order brain imaging such as MRI or CT scan, or refer to a neuropsychologist for comprehensive testing. In some cases, a positive AD8 turns out to reflect normal aging, medication side effects, or depression rather than dementia. In other cases, it leads to an earlier diagnosis of mild cognitive impairment or dementia than might otherwise have occurred—which can be valuable because some treatments and lifestyle interventions are most effective when started early. The key is that a positive AD8 is not an endpoint; it is a starting point for appropriate medical evaluation.
Conclusion
The AD8 Screening Questionnaire is a practical, evidence-based tool that helps identify people who may benefit from cognitive evaluation. Developed by the Washington University Knight Alzheimer Disease Research Center and validated in thousands of patients, the AD8 uses eight simple yes-or-no questions about memory, thinking, and daily functioning to flag cognitive changes that warrant further assessment. Its strength lies in its simplicity—anyone can understand and complete it—and in its reasonable balance between catching real cognitive impairment while avoiding excessive false alarms. If you are concerned about changes in someone’s thinking or memory, discussing those changes with their healthcare provider is the most important step.
The AD8 can provide useful structure and objectivity to that conversation, but it is not a replacement for medical evaluation. A positive screen means further testing is warranted. A negative screen does not rule out early changes. Either way, an open conversation with a doctor and attention to cognitive changes over time remains the foundation of early detection and appropriate care.
